NYSE: JNJJohnson & Johnson Stock
$165.11-0.51 (-0.31%)
Updated Oct 5, 2022
JNJ Price
$165.11
Fair Value Price
N/A
Market Cap
$434.10B
52 Week Low
$155.72
52 Week High
$186.69
P/E
23.62x
P/B
5.69x
P/S
4.94x
PEG
1.37x
Dividend Yield
2.65%
Revenue
$95.59B
Earnings
$18.37B
Gross Margin
67.9%
Operating Margin
21.46%
Profit Margin
19.2%
Debt to Equity
1.33
Operating Cash Flow
$24B
Beta
0.58
Next Earnings
Oct 18, 2022
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (49)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how JNJ scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
JNJ ($165.11) is trading below its intrinsic value of $262.21, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
JNJ is good value based on its earnings relative to its share price (23.62x), compared to the US market average (28.61x)
P/E vs Market Valuation
JNJ is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more JNJ due diligence checks available for Premium users.
Be the first to know about important JNJ news, forecast changes, insider trades & much more!
JNJ News
Valuation
JNJ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
23.62x
Industry
12.64x
Market
28.61x
JNJ is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
JNJ is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
JNJ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.69x
Industry
4.84x
JNJ is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
JNJ price to earnings growth (PEG)
For valuing profitable companies with growth potential
JNJ is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
JNJ's financial health
Profit margin
Revenue
$24.0B
Net Income
$4.8B
Profit Margin
20%
JNJ's Earnings (EBIT) of $20.52B... subscribe to Premium to read more.
Interest Coverage Financials
JNJ's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$177.7B
Liabilities
$101.4B
Debt to equity
1.33
JNJ's short-term assets ($63.85B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
JNJ's short-term assets ($63.85B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
JNJ's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
JNJ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$5.6B
Investing
-$2.6B
Financing
-$2.3B
JNJ's operating cash flow ($23.58B)... subscribe to Premium to read more.
Debt Coverage Financials
JNJ vs General Drug Manufacturer Stocks
Johnson & Johnson Stock FAQ
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.